Therapeutic resistance of pancreatic cancer: Roadmap to its reversal

S Yu, C Zhang, KP Xie - Biochimica et Biophysica Acta (BBA)-Reviews on …, 2021 - Elsevier
Pancreatic cancer is a lethal disease with limited opportunity for resectable surgery as the
first choice for cure due to its late diagnosis and early metastasis. The desmoplastic stroma …

[HTML][HTML] Neuropilin (NRPs) related pathological conditions and their modulators

M Broz, A Kolarič, M Jukič, U Bren - International journal of molecular …, 2022 - mdpi.com
Neuropilin 1 (NRP1) represents one of the two homologous neuropilins (NRP, splice
variants of neuropilin 2 are the other) found in all vertebrates. It forms a transmembrane …

[HTML][HTML] Antibody-mediated delivery of a viral MHC-I epitope into the cytosol of target tumor cells repurposes virus-specific CD8+ T cells for cancer immunotherapy

K Jung, MJ Son, SY Lee, JA Kim, DH Ko, S Yoo… - Molecular Cancer, 2022 - Springer
Background Redirecting pre-existing virus-specific cytotoxic CD8+ T lymphocytes (CTLs) to
tumors by simulating a viral infection of the tumor cells has great potential for cancer …

[HTML][HTML] VEGFA/NRP-1/GAPVD1 axis promotes progression and cancer stemness of triple-negative breast cancer by enhancing tumor cell-macrophage crosstalk

L Wang, L Zhang, L Zhao, S Shao, Q Ning… - … Journal of Biological …, 2024 - ncbi.nlm.nih.gov
Triple-negative breast cancer (TNBC) has long been considered a major clinical challenge
due to its aggressive behavior and poor prognosis. Cancer stem cells (CSCs) are known as …

Novel compounds targeting neuropilin receptor 1 with potential to interfere with SARS-CoV-2 virus entry

S Perez-Miller, M Patek, A Moutal… - ACS chemical …, 2021 - ACS Publications
Neuropilin-1 (NRP-1) is a multifunctional transmembrane receptor for ligands that affect
developmental axonal growth and angiogenesis. In addition to a role in cancer, NRP-1 is a …

Potential inhibitors interacting in Neuropilin-1 to develop an adjuvant drug against COVID-19, by molecular docking

JL Vique-Sánchez - Bioorganic & Medicinal Chemistry, 2021 - Elsevier
The COVID-19 pandemic continues without specific treatment. In this study it is proposed
compounds that can be developed as adjuvant/complementary drugs against COVID-19 …

[HTML][HTML] Chimeric antigen receptor-T cells are effective against CEACAM5 expressing non-small cell lung cancer cells resistant to antibody-drug conjugates

YJ Kim, W Li, DV Zhelev, JW Mellors… - Frontiers in …, 2023 - frontiersin.org
Chimeric antigen receptor-T (CAR-T) cells and antibody-drug conjugates (ADCs) are
promising therapeutic strategies in oncology. The carcinoembryonic antigen-related cell …

HMGB1 promotes the proliferation and metastasis of lung cancer by activating the Wnt/β-catenin pathway

X Wang, S Zhang, M Shi, X Xu - Technology in Cancer …, 2020 - journals.sagepub.com
The aim of this study was to investigate the role of high mobility group protein-1 (HMGB1) in
the proliferation and migration of lung cancer cells. CCK-8 assays and colony formation …

[HTML][HTML] Identification of key genes with differential correlations in lung adenocarcinoma

Y Zhou, B Xu, Y Zhou, J Liu, X Zheng, Y Liu… - Frontiers in cell and …, 2021 - frontiersin.org
Background With the advent of large-scale molecular profiling, an increasing number of
oncogenic drivers contributing to precise medicine and reshaping classification of lung …

Identified GNGT1 and NMU as combined diagnosis biomarker of non‐small‐cell lung cancer utilizing bioinformatics and logistic regression

JJ Zhang, J Hong, YS Ma, Y Shi, DD Zhang… - Disease …, 2021 - Wiley Online Library
Non‐small‐cell lung cancer (NSCLC) is one of the most devastating diseases worldwide.
The study is aimed at identifying reliable prognostic biomarkers and to improve …